Brilliant Violet 605a,,cents anti-human CD45 [HI30] and 2 more items

BioLegend Inc. was awarded a purchase order (PO-0478002) by the University of Virginia on September 9, 2026, valued at $704. The contract is for the procurement of laboratory reagents and diagnostic materials to be delivered to Jarred M Whitlock. The awarded products consist of three distinct line items: Brilliant Violet 605a anti-human CD45 [HI30] monoclonal antibody ($300.75), PE (phycoerythrin) anti-human CD16 [3G8] monoclonal antibody ($169.40), and Zombie NIR Fixable Viability Kit ($234.50). These materials are flow cytometry reagents used in immunological research and cell analysis applications.

The contract was executed in the Commonwealth of Virginia with the University of Virginia serving as the contracting organization. Each line item was procured in a quantity of one unit. No specific period of performance beyond the award date of September 9, 2026, is provided in the contract documentation. The cumulative contract value of $704 reflects the sum of the three individual reagent purchases, which are standardized laboratory products typically used in biomedical research settings.